Примери за използване на Standard chemotherapy на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
It achieves this better than standard chemotherapy alone.
The standard chemotherapy consisted of a platinum-based drug with"pemetrexed maintenance therapy.".
HI Status after the end of frontline standard chemotherapy.
Standard chemotherapy for patients with metastatic colorectal cancer who respond to treatment is often completely or partially discontinued until the disease progresses.
Glivec was also better than standard chemotherapy in patients with ALL.
Tarceva significantly reduced the risk of the disease getting worse by 63 percent compared with standard chemotherapy hazard ratio=0.37, p.
Zykadia was compared with standard chemotherapy(medicines to treat cancer).
Patients given Zykadia lived for an average of 16.6 months without their disease getting worse compared with 8.1 months in patients given standard chemotherapy.
Glivec was also better than standard chemotherapy in patients with Ph+ ALL.
Sensitivity analyses for both OS andEFS when censored at the time of SCT also supported the clinical benefit with midostaurin plus standard chemotherapy over placebo.
This is an advantage with respect to standard chemotherapy that target basically everything.".
All patients had liver-only or liver-dominant metastatic colorectal cancer(mCRC), andhad been randomized to receive either standard chemotherapy alone, or combined with SIRT.
The treatment worked in tandem with standard chemotherapy drugs to slow tumor growth in mouse studies.
They found that, in addition to improved response rates, rates of"overall andprogression-free survival" were greater in the group that received standard chemotherapy with pembrolizumab.
The treatment worked together with standard chemotherapy drugs to slow tumour growth in mouse studies.
Preliminary data from an early review showed a reduced survival with pembrolizumab monotherapy in patients whose tumours express PD-L1 with a CPS<10 compared with standard chemotherapy.
And this is an advantage with respect to standard chemotherapy, which targets basically everything.”.
In addition to standard chemotherapy, targeted therapy is a treatment that targets the tumor's specific genes, proteins, or the tissue environment that contributes to a tumor's growth and survival.
These newer chemotherapeutic agents most often are combined with standard chemotherapy to enhance their effectiveness.
Results showed that patients given Zykadia lived for an average of 5.4 months without their disease getting worse(progression-free survival)compared with 1.6 months in patients given standard chemotherapy.
This suggests that adding the immunotherapy drug to the platinum-based standard chemotherapy just about doubled overall and progression-free survival.
It is concluded that targeted therapy for NSCLC with ALK tyrosine kinase inhibitors as second line after crizotinib is not cost-effective in comparison with standard chemotherapy, based on the pemetrexed.
In the HERA trial, Herceptin was initiated after completions of standard chemotherapy(most commonly, anthracycline-containing regimens or anthracyclines plus a taxane).
The study assessed the efficacy and safety of trabectedin vs. best supportive care(BSC)as second-line or later therapy for patients with advanced TRS unresponsive or intolerant to standard chemotherapy regimen.
The overall rate of SCT was 59.4%(214/360) of patients in the midostaurin plus standard chemotherapy arm versus 55.2%(197/357) in the placebo plus standard chemotherapy arm.
The efficacy and safety of midostaurin in combination with standard chemotherapy versus placebo plus standard chemotherapy and as single agent maintenance therapy was investigated in 717 patients(18 to 60 years of age) in a randomised, double-blind, phase III study.
Long-term treatment of two metastatic uveal melanoma patients with Artemisinin in combination with standard chemotherapy showed a significant improvement(R).
This study looked at the effectiveness of adding MabThera to standard chemotherapy(CVP: cyclophosphamide, vincristine and prednisolone) by measuring how long it took for the treatment to fail.
It is concluded that targeted immunotherapy for NSCLC with PD-L1 expression is cost-effective in comparison with standard chemotherapy, therefore, it is applicable as second line after previous chemotherapy. .
The EFS showed a statistically significant improvement for midostaurin plus standard chemotherapy over placebo plus standard chemotherapy(HR: 0.78[95% CI, 0.66 to 0.93] p= 0.0024), and a median EFS of 8.2 months and 3.0 months, respectively; see Table 5.